Figure 1. Morbidity tendency of female neuroendocrine neoplasms (fNENs) patients by age, race, stage, grade, and site. (A) The age-adjusted incidence of women patients in all cancers (right Y) and Neuroendocrine neoplasms (NENs) (left Y) during 2000-2018. (B) The fNENs incidence by age. (C) The incidence of fNENs in different races. (D) The incidence of fNENs by grade. (E) Incidence of fNENs by stage. (F) The incidence of fNENs by the site.